Hello everyone!
Recently, it has been reported that Eli Lilly, a leading company in the production of diabetes medicines, has seen an increase of 40% in its net benefits this quarter, largely driven by the sales of its products for diabetes, such as'Mounjaro 'and' Jardiance '.Although we are glad to see the success of innovative treatments, this also raises important questions about the costs that people with diabetes face.
With significantly increased income, it would now be an appropriate time for Eli Lilly to consider how it can contribute even more to the well -being of the community of people with diabetes.
Many patients fight with the high costs of insulin and other essential medications for life.Despite the innovations in treatment, access to these medications remains a critical challenge for many.
Eli Lilly could use part of these profits to:
1.Reducing insulin prices and other essential medications: making the most accessible treatments could significantly improve the quality of life of millions of people.
2.Expand patient assistance programs: Increase financial support and subsidy programs for those who have difficulty paying their medications.
3.Invest in research and development: Continue improving existing treatments and discover new therapies that may be more effective or easier to use.
4.Improving education and diabetes management resources: Providing more educational resources and support for diabetes management can help prevent complications and improve long -term health results.
As members of the community, it is essential that we advocate for ourselves and ask companies that not only focus on profitability but also on corporate social responsibility.
Accessibility to affordable treatments is essential for all patients to manage their health effectively.
Let us continue the dialogue and press so that the necessary changes are made, ensuring that innovations in the treatment of diabetes benefit all those who suffer from it, not only those who can afford to pay.
And what do you think, will invest Eli Lilly in any of the previous points or will distribute benefits with investors and shareholders?
Greetings,
